Lindsay Modglin's profile photo

Lindsay Modglin

Indianapolis

Writer, Editor, and SEO Specialist at Freelance

Freelance Writer | SEO Editor | Health & Wellness | Medical | Travel | Nurse Byline in Verywell, Insider, Forbes, Parents, Giddy, and more.

Articles

  • 1 week ago | patientpower.info | Lindsay Modglin

    Jump ToEndometriosisEndometrial CancerKey DifferencesCausesRisk FactorsSymptomsDiagnosisEndometriosis TreatmentEndometrial Cancer TreatmentCancer RiskSee a DoctorTakeawayEndometriosis and endometrial cancer are two distinct conditions affecting the female reproductive system. Both affect the uterus and pelvic organs, but they differ in terms of causes, symptoms, and treatments.

  • 1 week ago | patientpower.info | Lindsay Modglin

    POT1 tumor predisposition syndrome (POT1-TPDS) is a rare hereditary condition that significantly increases your risk for certain cancers, including chronic lymphocytic leukemia (CLL). Recent research presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting offers valuable insights into the other types of cancer people with POT1-TPDS may be most at risk for. What Is POT1-TPDS?

  • 2 weeks ago | patientpower.info | Lindsay Modglin

    Jump ToWhat It IsSymptomsRisk FactorsDiagnosisStagingTreatmentChemo Side EffectsPrognosisTakeawayNodular sclerosis Hodgkin lymphoma (NSHL) is the most common type of classical Hodgkin lymphoma (cHL). It accounts for around 70% of cHL cases, according to the Leukemia and Lymphoma Society. The condition primarily affects teens and young adults, with the average age at diagnosis being 28 years old. What It IsWhat is Nodular Sclerosis Hodgkin Lymphoma?

  • 2 weeks ago | patientpower.info | Lindsay Modglin

    If you're living with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), you've likely heard about Bruton tyrosine kinase inhibitors (BTK inhibitors). These oral medications have transformed treatment for blood cancers. But like many cancer treatments, they come with their own set of challenges. Recent research and data presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting shed light on the cardiovascular side effects of different BTK inhibitors.

  • 3 weeks ago | patientpower.info | Lindsay Modglin

    Jump ToLight Chain and Heavy ChainRisk FactorsSymptomsDiagnosisTreatmentOutlookTakeawayLight chain myeloma, also called Bence Jones myeloma, is a rare and aggressive subtype of multiple myeloma. Multiple myeloma is a cancer affecting cells in the bone marrow called plasma cells. The light chain is one component of a larger protein molecule called an immunoglobulin, which plasma cells make.

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

X (formerly Twitter)

Followers
18
Tweets
0
DMs Open
No
No Tweets found.